CIAM
SLDB icon

Caitong International Asset Management’s Solid Biosciences SLDB Stock Holding History

Caitong International Asset Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.62K Buy
+563
New +$4.27K ﹤0.01% 1273
2025
Q2 		– Sell
-1,992
Closed -$7.37K – 2445
2025
Q1 		$7.37K Buy
1,992
+1,974
+10,967% +$8.45K 0.01% 931
2024
Q4 		$72 Buy
+18
New +$99 ﹤0.01% 1630

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caitong International Asset Management's SLDB Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Solid Biosciences (SLDB) in Q2 2026: 563 shares worth $5.62K. The stake represents ﹤0.01% of the portfolio and ranks #1273 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in SLDB as recently as Q1 2025.

Caitong International Asset Management first reported a position in SLDB in Q4 2024 and has held it in 3 quarters since. The position peaked at $7.37K in Q1 2025. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Caitong International Asset Management held 563 shares of Solid Biosciences worth $5.62K as of Q2 2026.
  • Solid Biosciences was a new Caitong International Asset Management position in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1273 holding.
  • Caitong International Asset Management first reported a position in Solid Biosciences in Q4 2024 and has held it in 3 quarters since.
  • Caitong International Asset Management's Solid Biosciences position peaked at $7.37K in Q1 2025.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.